Oblique Therapeutics Company
Oblique Therapeutics is developing a new type of antibody-based medication for chronic pain and metastatic cancer.
Founded Date:
2015
Last Funding Type:
Pre-Seed
Headquarters:
GРЄ њРЎteborg, Vastra Gotaland, Sweden
Technology:
Anti-infective Drugs
Employee Number:
1-10
Industry:
PharmTech
Estimated Revenue:
Less than $1M
Total Funding:
€130K